Omega-3 supplementation during pregnancy reduces risk of preterm birth

Middleton P, Gomersall JC, Gould JF, Shepherd E, Olsen SF, Makrides M.

Omega-3 supplementation during pregnancy reduces risk of preterm birth

9 May 2025

This Cochrane systematic review assessed the effects of omega-3 long-chain polyunsaturated fatty acid (LCPUFA) supplementation during pregnancy on maternal and infant health outcomes.

Analysing data from 70 randomised controlled trials involving over 19,000 pregnant women, the study found that omega-3 LCPUFA supplementation significantly reduced the risk of preterm birth (before 37 weeks) by 11% and early preterm birth (before 34 weeks) by 42%. 

The review also noted a slight increase in gestational length (mean difference of 1.67 days) and a potential reduction in the risk of low birth weight infants. However, there was little or no difference observed in outcomes such as small-for-gestational-age births, intrauterine growth restriction, or maternal adverse events.

These findings suggest that omega-3 LCPUFA supplementation during pregnancy is an effective strategy for reducing the incidence of preterm birth, with minimal associated risks.

Omega-3 fatty acid addition during pregnancy
Middleton P, Gomersall JC, Gould JF, Shepherd E, Olsen SF, Makrides M. Cochrane Database Syst Rev. 2018 Nov 15;11(11):CD003402. doi:10.1002/14651858.CD003402.pub3.eScholarship+2NCBI+2PubMed+2

https://pubmed.ncbi.nlm.nih.gov/30480773/

Spread the word
DHA NurtureOmega Omega-3 preterm birth Research
Back to blog